shutterstock_1730094274_metamorworks
metamorworks / Shutterstock.com
24 June 2021Big PharmaMuireann Bolger

SPCs outlive patent protections in 91% of cases, new report reveals

Supplementary protection certificates (SPCs) outlive medicinal patents in more than nine in ten cases, a new report has found.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

More on this story

Generics
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

More on this story

Generics
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.